tiprankstipranks
Trending News
More News >
Ajinomoto Co Inc (JP:2802)
:2802

Ajinomoto Co (2802) AI Stock Analysis

Compare
3 Followers

Top Page

JP:2802

Ajinomoto Co

(2802)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
¥4,855.00
▲(5.50% Upside)
Action:ReiteratedDate:02/07/26
Overall score reflects solid underlying financial health and profitability with manageable leverage, tempered by materially weaker free cash flow momentum. Technicals are supportive but look overbought, and valuation is the primary drag due to a high P/E and modest yield.
Positive Factors
Scale and core profitability
Ajinomoto's large revenue base (TTM ¥1.54T) combined with ~37% gross and ~14% EBITDA margins indicate durable core profitability and operational scale. This supports steady cash generation potential and competitive cost absorption across cycles, underpinning multi-month strategic resilience.
Manageable leverage and capital base
A ~0.60 debt-to-equity with a ¥744B equity base and ~9.6% ROE provides financial flexibility to fund operating needs and strategic investments. Moderate leverage reduces refinancing stress risk over the next few quarters, supporting durable investment-grade style stability for operations.
Proprietary fermentation & diversified business model
Ajinomoto's specialized amino-acid and fermentation capabilities create product differentiation across consumer, B2B ingredients and health segments. This diversified, IP-linked model reduces reliance on any single channel and supports lasting revenue resilience and cross-market application of core technology.
Negative Factors
Sharp free cash flow decline
A steep -79% decline in FCF growth despite positive OCF signals weaker cash conversion drivers (working capital or capex pressure). Over a 2–6 month horizon this reduces buffer for reinvestment or cushioning against operational shocks and constrains strategic optionality.
Modest and slipping net margins
While gross and EBITDA margins are solid, a ~5% net margin that has declined from prior peaks suggests pressure from mix, cost inflation or non-operating items. Persistently compressed net margins limit retained earnings and long-term reinvestment capacity versus peers.
Rising debt reduces balance sheet flexibility
Debt has risen relative to FY2023, narrowing headroom. If operating performance weakens or cash flow stays depressed, higher indebtedness could pressure liquidity and limit capital allocation choices over the next several quarters, raising execution risk on strategic initiatives.

Ajinomoto Co (2802) vs. iShares MSCI Japan ETF (EWJ)

Ajinomoto Co Business Overview & Revenue Model

Company DescriptionAjinomoto Co., Inc. engages in the seasonings and foods, frozen foods, and healthcare and other businesses in Japan and internationally. Its Seasonings and Foods segment offers sauces and seasonings products under the AJI-NO-MOTO, HON-DASHI, Cook Do, Ajinomoto KK Consommé, Pure Select Mayonnaise, Ros Dee, Masako, Aji-ngon, Sazón, Sajiku, and CRISPY FRY names; and solutions and ingredients to consumer foods and food service industries. This segment also provides instant noodles under the Knorr Cup Soup, and YumYum names; coffee under the Birdy and Blendy brands; powdered drink under the Birdy 3in1 name; MAXIM products; Chyotto Zeitakuna Kohiten products; and gift sets and office supplies comprising coffee vending machines, tea server, etc. The Frozen Foods segment offers Chinese dumplings, cooked rice, noodles, desserts, shumai, processed chicken, and other products. The Healthcare and Other segment provides amino acids to various industries, such as pharmaceuticals, foods, and cosmetics; sports nutrition products; personal care ingredients; and sterile products, as well as engages in the provision of contract manufacturing services for pharmaceutical intermediates and active ingredients. This segment also offers Ajinomoto Build-up Film, an interlayer insulating material for semiconductor packages. Ajinomoto Co., Inc. was founded in 1909 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyAjinomoto generates revenue through several key streams. The Food Products segment, which includes seasonings, processed foods, and beverages, constitutes a significant portion of its income, driven by strong consumer demand in both domestic and international markets. The Amino Acids segment contributes to revenue through the sale of amino acids and related products for food, pharmaceuticals, and animal nutrition, leveraging the growing market for health and wellness products. The company also benefits from strategic partnerships and collaborations with other businesses in various sectors, enhancing its product offerings and expanding its market reach. Additionally, Ajinomoto invests in research and development to innovate and improve its products, which helps maintain a competitive edge and stimulate sales growth.

Ajinomoto Co Earnings Call Summary

Earnings Call Date:May 07, 2026
(Q4-2025)
|
Next Earnings Date:May 07, 2026
Earnings Call Sentiment Neutral
Ajinomoto's earnings call showcased strong revenue and profit growth, particularly in the Seasonings & Foods segment, and projected a positive outlook for FY 2025. However, the company faced challenges in the Frozen Foods segment and experienced a decline in profit attributable to the parent company due to structural reforms. Delays in Bio-Pharma Services shipments and potential impacts from tariffs and economic uncertainties were noted. Overall, the highlights slightly outweigh the lowlights, indicating a cautiously optimistic sentiment.
Q4-2025 Updates
Positive Updates
Record-Breaking Revenue and Growth
Sales in FY 2024 reached JPY1.530 trillion, an increase of 6% year-on-year, and business profit was JPY159.3 billion, an increase of 7.9% year-on-year. Revenue and profit are projected to increase further in FY 2025.
Strong Performance in Seasonings & Foods
Seasonings & Foods overseas continued to perform strongly, driving increased revenue overall. Both unit prices and volume increased by 3% overseas, resulting in a 6% sales growth on a local currency basis.
Significant Projected Increase in Profit for FY 2025
Ajinomoto forecasts a business profit of JPY180 billion for FY 2025, representing a 13% increase year-on-year. The Bio-Pharma Services & Ingredients segment is expected to significantly drive profit growth.
Positive Cash Flow and Shareholder Returns
Ajinomoto generated over JPY200 billion in operating cash flow in FY 2024 and plans to repurchase JPY100 billion in shares, enhancing shareholder returns.
New Business Initiatives and Expansions
Ajinomoto is focusing on new business initiatives such as amino acid feed to reduce greenhouse gases and fertilizer projects in Brazil, which are expected to contribute positively in the future.
Negative Updates
Challenges in the Frozen Foods Segment
The Frozen Foods segment struggled in Japan due to high raw material costs and the impact of currency translation, resulting in decreased profit.
Decline in Profit Attributable to Parent Company
Profit attributable to owners of the parent company decreased significantly due to structural reform expenses and the recording of an impairment loss from the sale of the Hayward Plant in North America.
Delays in Bio-Pharma Services Shipments
The Bio-Pharma Services segment faced delays in shipments, impacting the business profit forecast for FY 2024.
Impact of Tariffs and Economic Uncertainty
There is concern about potential impacts from tariffs and economic policy changes, especially affecting the CDMO and semiconductor businesses.
Company Guidance
During the Ajinomoto fiscal year 2024 results briefing, the company's leadership provided guidance for fiscal year 2025, highlighting several key metrics and strategic initiatives. Ajinomoto reported record sales of JPY1.530 trillion for FY 2024, marking a 6% year-on-year increase, and a 4% rise excluding currency translation impacts. Business profit reached JPY159.3 billion, representing a 7.9% increase year-on-year, or 4.5% without currency translation effects. Looking forward, Ajinomoto forecasts continued revenue and profit growth for FY 2025, with projected sales of JPY1.618 trillion, a 5.7% increase year-on-year, or 6.7% when excluding currency translation impacts. Business profit is expected to rise by 13% to JPY180 billion. The company is also committed to shareholder returns, planning to increase dividends and repurchase shares. Ajinomoto aims to enhance corporate value through strategic initiatives like evolving ASV (Ajinomoto Shared Value) indicators, with ROE and ROIC targets set at 19% and 12%, respectively, excluding the impact of the Forge acquisition. The company is focused on boosting its operating cash flow to over JPY220 billion and plans significant investments in intangible assets to support sustainable growth.

Ajinomoto Co Financial Statement Overview

Summary
Solid scale and profitability (TTM revenue ¥1.54T; ~37% gross margin; ~14% EBITDA margin) with manageable leverage (debt-to-equity ~0.60). Offsetting this, net margin is modest (~5%) and below recent peaks, and cash flow quality weakened as TTM free cash flow fell sharply (-79%) with only moderate cash conversion (~56% of net income).
Income Statement
74
Positive
TTM (Trailing-Twelve-Months) revenue is ¥1.54T with strong reported growth (121%), and profitability remains solid with ~37% gross margin and ~14% EBITDA margin. However, net margin is modest (~5%), and profitability appears below prior peaks (FY2023–FY2024 net margins were higher), suggesting either mix/price pressure, higher costs, or non-operating headwinds. Overall: good core profitability and scale, but margins and earnings quality look less robust than a year or two ago.
Balance Sheet
70
Positive
Leverage is moderate: TTM debt-to-equity is ~0.60, in line with recent history and not excessive for a large packaged foods business. Equity base is sizable (¥744B) and returns are steady (ROE ~9.6% TTM), though down from earlier highs (low double-digits in FY2022–FY2024). The main watch item is balance sheet flexibility: debt increased versus FY2023 levels, which reduces room for error if profitability softens.
Cash Flow
58
Neutral
Cash generation is positive (TTM operating cash flow ¥225B; free cash flow ¥126B), but momentum is a concern: TTM free cash flow growth is sharply negative (-79%). Cash conversion is also only moderate, with free cash flow running at ~56% of net income TTM, implying working-capital or capital spending pressure. While cash flow covered debt at a reasonable level, the recent decline in free cash flow lowers financial flexibility versus prior years.
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue1.54T1.53T1.44T1.36T1.15T1.07T
Gross Profit574.13B550.76B511.45B470.39B425.90B406.22B
EBITDA211.56B209.22B232.75B226.85B197.67B168.07B
Net Income77.58B70.27B87.12B94.06B75.72B59.42B
Balance Sheet
Total Assets1.90T1.72T1.77T1.51T1.46T1.43T
Cash, Cash Equivalents and Short-Term Investments201.84B164.78B171.54B132.78B151.45B181.61B
Total Debt446.93B496.06B491.68B336.50B363.96B406.82B
Total Liabilities1.08T907.86B890.43B688.77B717.32B763.44B
Stockholders Equity743.55B746.80B814.69B768.68B686.91B620.26B
Cash Flow
Free Cash Flow126.14B121.79B102.29B49.26B71.73B88.76B
Operating Cash Flow224.97B209.90B168.07B117.64B145.58B165.65B
Investing Cash Flow-107.01B-77.38B-132.43B-30.09B-61.57B-66.25B
Financing Cash Flow-147.54B-137.68B-6.75B-111.06B-123.06B-60.39B

Ajinomoto Co Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4602.00
Price Trends
50DMA
3650.30
Positive
100DMA
3794.14
Positive
200DMA
3810.60
Positive
Market Momentum
MACD
301.36
Negative
RSI
79.37
Negative
STOCH
76.17
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2802, the sentiment is Positive. The current price of 4602 is above the 20-day moving average (MA) of 4025.55, above the 50-day MA of 3650.30, and above the 200-day MA of 3810.60, indicating a bullish trend. The MACD of 301.36 indicates Negative momentum. The RSI at 79.37 is Negative, neither overbought nor oversold. The STOCH value of 76.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2802.

Ajinomoto Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
¥1.23T18.5813.26%1.82%3.64%5.31%
72
Outperform
¥1.43T23.3411.19%1.46%2.65%-5.76%
72
Outperform
€520.29B19.789.86%2.58%1.08%2.71%
71
Outperform
¥630.11B20.559.28%1.30%5.50%27.32%
66
Neutral
¥958.55B18.669.77%2.41%1.46%-2.17%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
61
Neutral
¥4.51T58.309.46%1.32%1.99%-18.79%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2802
Ajinomoto Co
4,602.00
1,681.20
57.56%
JP:2801
Kikkoman
1,483.00
69.92
4.95%
JP:2897
Nissin Foods Holdings Co
3,229.00
368.44
12.88%
JP:2875
Toyo Suisan Kaisha
12,000.00
3,119.97
35.13%
JP:2809
Kewpie Corporation
4,462.00
1,712.55
62.29%
JP:2871
Nichirei Corporation
2,079.00
384.67
22.70%

Ajinomoto Co Corporate Events

Ajinomoto to Sell Tokyo Head Office Property, Booking Large Capital Gain
Feb 5, 2026

Ajinomoto Co., Inc. has resolved to transfer the land and building of its head office in Kyobashi, Chuo-ku, Tokyo as part of a broader initiative to improve capital efficiency and support its previously announced head office relocation. The fixed assets, with an IFRS book value of approximately ¥4.5 billion and a sale price of about ¥45.1 billion, are expected to generate an estimated capital gain of roughly ¥40.6 billion on a consolidated basis, which will be recognized as other operating income in the fourth quarter of the fiscal year ending March 31, 2026. The transferees are domestic corporations selected through competitive bidding at fair market prices, and the transaction is set to close on February 27, 2026, underscoring Ajinomoto’s ongoing efforts to optimize its balance sheet and redeploy capital while maintaining normal business relationships with counterparties.

The most recent analyst rating on (JP:2802) stock is a Hold with a Yen3498.00 price target. To see the full list of analyst forecasts on Ajinomoto Co stock, see the JP:2802 Stock Forecast page.

Ajinomoto Cuts Sales Outlook but Lifts Profit Forecast for FY2025
Feb 5, 2026

Ajinomoto has revised its full-year consolidated forecast for the fiscal year ending March 31, 2026, trimming projected sales to ¥1.6 trillion from ¥1.618 trillion but slightly increasing its business profit outlook to ¥181 billion and sharply raising profit attributable to owners of the parent to ¥130 billion. The downgrade in revenue reflects weaker-than-expected sales in the Seasonings and Foods and Frozen Foods segments, partially offset by stronger performance in Healthcare and Others, while the profit upgrade is driven by improved margins, segment-level profit gains in core and healthcare businesses, and an anticipated gain on the sale of non-current assets. These revisions suggest that despite a softer top line, Ajinomoto is managing costs and portfolio profitability effectively, bolstering earnings per share and underscoring resilience in its profit structure amid changing economic conditions and input costs.

The most recent analyst rating on (JP:2802) stock is a Hold with a Yen3498.00 price target. To see the full list of analyst forecasts on Ajinomoto Co stock, see the JP:2802 Stock Forecast page.

Ajinomoto Lifts Full-Year Outlook as Profit Climbs on Modest Sales Growth
Feb 5, 2026

Ajinomoto reported modest top-line growth for the nine months ended December 31, 2025, with sales rising 1.1% year-on-year to ¥1.16 trillion, while business profit increased 5.6% to ¥145.99 billion and profit attributable to owners of the parent climbed 8.9% to ¥89.75 billion, reflecting improved profitability and higher earnings per share despite only marginal sales expansion. Total assets expanded to ¥1.90 trillion and operating cash flow strengthened to ¥164.36 billion, even as investing and financing outflows increased, and the company confirmed an annual dividend forecast equivalent to ¥48 per share post–stock split; Ajinomoto also upgraded its full-year outlook, projecting 4.5% sales growth and a 13.6% rise in business profit, alongside a sharp 85% jump in profit attributable to owners of the parent, signaling confidence in earnings momentum and shareholder returns.

The most recent analyst rating on (JP:2802) stock is a Hold with a Yen3498.00 price target. To see the full list of analyst forecasts on Ajinomoto Co stock, see the JP:2802 Stock Forecast page.

Ajinomoto Reports Progress on Ongoing Share Buyback and Planned Share Cancellation
Feb 3, 2026

Ajinomoto has reported progress on a previously approved share buyback program, repurchasing 2,706,300 common shares for approximately JPY 9.24 billion on the Tokyo Stock Exchange between January 1 and January 31, 2026. This brings cumulative repurchases under the program, which runs from December 1, 2025 to November 30, 2026 and is capped at 30 million shares and JPY 80 billion, to 5,457,000 shares for about JPY 18.57 billion; the company plans to cancel all shares acquired, a move that could enhance capital efficiency and shareholder value by reducing the total number of shares outstanding.

The most recent analyst rating on (JP:2802) stock is a Hold with a Yen3498.00 price target. To see the full list of analyst forecasts on Ajinomoto Co stock, see the JP:2802 Stock Forecast page.

Ajinomoto Revamps Top Executive Lineup to Bolster Global Food Business
Jan 29, 2026

Ajinomoto Co., Inc. has announced executive leadership changes effective April 1, 2026, appointing Hiroshi Kaho as Representative Executive Officer & Executive Vice President and Chief Human Resources Officer, and Ichiro Sakakura as Representative Executive Officer & Senior Vice President and General Manager of the Food Products Division. The reshuffle, which also includes the retirement of Executive Vice President and Chief Innovation Officer Hiroshi Shiragami, signals a strategic strengthening of the company’s global management structure by elevating leaders with extensive international and regional experience in North America, Europe, Africa, and ASEAN markets, potentially sharpening its focus on human capital, core food products, and overseas expansion.

The most recent analyst rating on (JP:2802) stock is a Hold with a Yen3498.00 price target. To see the full list of analyst forecasts on Ajinomoto Co stock, see the JP:2802 Stock Forecast page.

Ajinomoto Reports Initial Progress on ¥80 Billion Share Buyback Program
Jan 6, 2026

Ajinomoto Co., Inc. reported progress on its share repurchase program authorized by the board on November 6, 2025, announcing that it bought back 2,750,700 common shares for approximately JPY 9.33 billion on the Tokyo Stock Exchange between December 1 and December 31, 2025. This buyback is part of a larger program allowing repurchases of up to 30 million shares or JPY 80 billion through November 30, 2026, with the company planning to cancel all shares acquired under the program, a move that is expected to enhance capital efficiency and potentially support shareholder value by reducing the number of shares outstanding.

The most recent analyst rating on (JP:2802) stock is a Hold with a Yen3414.00 price target. To see the full list of analyst forecasts on Ajinomoto Co stock, see the JP:2802 Stock Forecast page.

Ajinomoto to Cancel 27.9 Million Treasury Shares, Cutting Float by 2.77%
Dec 24, 2025

Ajinomoto Co., Inc. has resolved to cancel 27,902,000 of its common treasury shares, representing 2.77% of its issued shares, following acquisitions conducted via off-auction own share repurchase trading and market purchases on the Tokyo Stock Exchange between May 9 and November 17, 2025. The cancellation, scheduled for January 26, 2026, will reduce the company’s total shares outstanding to 977,735,616, a move that is expected to enhance capital efficiency and potentially improve per-share metrics for existing shareholders.

The most recent analyst rating on (JP:2802) stock is a Hold with a Yen3414.00 price target. To see the full list of analyst forecasts on Ajinomoto Co stock, see the JP:2802 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 07, 2026